Rockefeller Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-46,417
| Closed | -$343K | – | 1701 |
|
|
2024
Q4 | $343K | Buy |
46,417
+3,266
| +8% | +$24.2K | ﹤0.01% | 1573 |
|
|
2024
Q3 | $405K | Buy |
43,151
+239
| +0.6% | +$2.24K | ﹤0.01% | 1492 |
|
|
2024
Q2 | $344K | Buy |
42,912
+361
| +0.8% | +$2.9K | ﹤0.01% | 1525 |
|
|
2024
Q1 | $631K | Buy |
42,551
+2,678
| +7% | +$39.7K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $324K | Buy |
+39,873
| New | +$324K | ﹤0.01% | 1448 |
|
|
2023
Q3 | – | Sell |
-37,758
| Closed | -$266K | – | 1661 |
|
|
2023
Q2 | $266K | Buy |
37,758
+1,385
| +4% | +$9.75K | ﹤0.01% | 1552 |
|
|
2023
Q1 | $221K | Buy |
36,373
+2,000
| +6% | +$12.2K | ﹤0.01% | 1765 |
|
|
2022
Q4 | $219K | Buy |
34,373
+3,500
| +11% | +$22.3K | ﹤0.01% | 1624 |
|
|
2022
Q3 | $295K | Sell |
30,873
-682
| -2% | -$6.52K | ﹤0.01% | 1474 |
|
|
2022
Q2 | $347K | Buy |
31,555
+8,871
| +39% | +$97.6K | ﹤0.01% | 1413 |
|
|
2022
Q1 | $377K | Sell |
22,684
-308
| -1% | -$5.12K | ﹤0.01% | 1430 |
|
|
2021
Q4 | $438K | Buy |
22,992
+22,642
| +6,469% | +$431K | ﹤0.01% | 1366 |
|
|
2021
Q3 | $8K | Sell |
350
-150
| -30% | -$3.43K | ﹤0.01% | 2992 |
|
|
2021
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 2669 |
|
|
2021
Q1 | $15K | Hold |
500
| – | – | ﹤0.01% | 2412 |
|
|
2020
Q4 | $23K | Sell |
500
-412
| -45% | -$19K | ﹤0.01% | 1952 |
|
|
2020
Q3 | $30K | Buy |
912
+49
| +6% | +$1.61K | ﹤0.01% | 1655 |
|
|
2020
Q2 | $24K | Sell |
863
-67
| -7% | -$1.86K | ﹤0.01% | 1617 |
|
|
2020
Q1 | $28K | Buy |
930
+180
| +24% | +$5.42K | ﹤0.01% | 1406 |
|
|
2019
Q4 | $21K | Buy |
+750
| New | +$21K | ﹤0.01% | 1378 |
|
|
2019
Q2 | – | Sell |
-82
| Closed | -$1K | – | 1802 |
|
|
2019
Q1 | $1K | Buy |
+82
| New | +$1K | ﹤0.01% | 1860 |
|